BOULDER, Colo., Feb. 2, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual Global Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Array BioPharma.

 

Event:                

Leerink Partners Annual Global Healthcare Conference

Presenter:          

Ron Squarer, Chief Executive Officer

Date:                 

Wednesday, February 10, 2016

Time:              

8:00 a.m. Eastern Time

Location:            

The Waldorf Astoria, New York, NY

Webcast:           

http://wsw.com/webcast/leerink26/arry

About Array BioPharma
 Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:   

Tricia Haugeto

Array BioPharma Inc.

303-386-1193

thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

SOURCE Array BioPharma Inc.

Copyright 2016 PR Newswire

Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Array Technologies Charts.
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Array Technologies Charts.